Holen Sie sich die Stockscreener-App
3.105
1.11%
-0.035
Schlusskurs vom Vortag:
$3.14
Offen:
$3.17
24-Stunden-Volumen:
328.33K
Relative Volume:
0.76
Marktkapitalisierung:
$61.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.7763
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-3.27%
1M Leistung:
+5.25%
6M Leistung:
+47.86%
1J Leistung:
+140.70%
1-Tages-Spanne:
$3.00
$3.25
1-Wochen-Bereich:
$3.00
$3.3154
52-Wochen-Spanne:
$1.12
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.11 | 74.64M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.60 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.83 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.68 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
831.15 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.10 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Is NRx Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Lancaster Eagle-Gazette
Using AI based signals to follow NRx Pharmaceuticals Inc. Equity WarrantQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
What indicators show strength in NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com
Is NRx Pharmaceuticals Inc. meeting your algorithmic filter criteriaRate Hike & Safe Swing Trade Setups - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upsideMarket Trend Report & Trade Opportunity Analysis - newser.com
Is it time to cut losses on NRx Pharmaceuticals Inc.July 2025 EndofMonth & Daily Profit Focused Screening - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soonTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
How NRx Pharmaceuticals Inc. stock reacts to Fed rate cutsMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for NRx Pharmaceuticals Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to analystsBear Alert & Daily Price Action Insights - newser.com
Using AI based signals to follow NRx Pharmaceuticals Inc.Weekly Gains Report & Expert Approved Trade Ideas - newser.com
Market reaction to NRx Pharmaceuticals Inc.’s recent newsInsider Selling & Technical Pattern Based Buy Signals - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than market2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
Published on: 2025-10-27 23:50:51 - newser.com
What candlestick patterns are forming on NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Fast Gaining Stock Reports - newser.com
Is NRx Pharmaceuticals Inc. stock a safe buy before earningsPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Real time breakdown of NRx Pharmaceuticals Inc. stock performanceJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical toolsWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - NewMediaWire
NRx Pharmaceuticals (NASDAQ: NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - Digital Journal
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com
Using fundamentals and technicals on NRx Pharmaceuticals Inc.Weekly Investment Report & Entry Point Confirmation Signals - newser.com
Using data models to predict NRx Pharmaceuticals Inc. stock movementGap Down & Entry and Exit Point Strategies - newser.com
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stock2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.41%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):